PerkinElmer (PKI) PT Raised to $91 at Piper Jaffray

January 26, 2018 9:07 AM EST
Get Alerts PKI Hot Sheet
Price: $185.07 +0.67%

Rating Summary:
    13 Buy, 14 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 7 | Down: 15 | New: 3
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Piper Jaffray raised its price target on PerkinElmer (NYSE: PKI) to $91.00 (from $81.00) while maintaining a Overweight rating.

Analyst William Quirk commented, "PerkinElmer delivered a good 4Q17 beat, with 13% revenue growth to $641.6M (+6% organic), ahead of the Street's $618.7M estimate (+4.8% organic). Normalized EPS of $0.97 was also above Consensus' $0.94 expectation. 2018 revenue guidance is $2.72B-$2.74B with $3.50 in EPS, both of which are above the Street's $2.64B and $3.45 estimates, respectively. We anticipate EUROIMMUNE can help accelerate Perkin's Diagnostics business and are raising our estimates and price target to $91 (was $81), based 23x FY19E EPS (was FY18E EPS)."

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

Piper Jaffray